Davies Collison Cave | Australia | 5 May 2020
The Federal Court of Australia has rejected the Australian Government’s claim for $325 million in damages from Sanofi. The claim was made under a…
Davies Collison Cave | Australia | 30 Apr 2020
On 28 April 2020, Justice Nicholas handed down his decision in the case of the Commonwealth (Australian Department of Health) v Sanofi (Commonwealth…
Davies Collison Cave | Australia | 20 Dec 2017
In a judgment handed down on 18 December 2017, Justice Beach of the Federal Court of Australia has questioned the appropriateness of a patent…
Davies Collison Cave | Australia, United Kingdom | 28 Nov 2016
In the recent decision of Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) [2016] FCA 1238, the Federal Court has upheld the validity of Pfizer's…
Davies Collison Cave | Australia, Canada | 24 Feb 2014
Justice Robertson of the Federal Court of Australia has recently dismissed an appeal against the Commissioner of Patent's finding that key claims of a…
Davies Collison Cave | Australia | 6 Feb 2014
He Therapeutic Products Advertising Complaints Resolution Panel has requested that Chemist Warehouse formally retract "health information" web pages…
Davies Collison Cave | Australia | 5 Dec 2013
The Australian Federal Court has recently made orders preventing generic pharmaceutical company, Generic Health, from promoting and selling generic…
Davies Collison Cave | Australia | 30 Jan 2013
In a continuation of a battle between two printer cartridge resellers, the Full Federal Court has affirmed the legal principles pronounced by the…
Davies Collison Cave | Australia | 14 Nov 2012
The Federal Court has recently made orders restraining Hospira from promoting, supplying and obtaining PBS listing of products containing zoledronic acid until its final determination of Novartis’ allegations of patent infringement and Hospira’s cross-claims for invalidity.
Davies Collison Cave | Australia | 11 Sep 2012
Justice Jagot of the Federal Court has granted an interlocutory injunction prohibiting the promotion and sale of Apotex's generic versions of Merck's anti-allergic nasal spray, Nasonex.